Table II.
Baseline patient characteristics
| Characteristic | ICS + LTRA (n = 10) | ICS (n = 18) | P-value |
|---|---|---|---|
| Age (years) | 45.8 ± 16.8 | 44.6 ± 14.5 | 0.85 |
| Gender (male/female) | 7/3 | 8/10 | 0.19 |
| Height (cm) | 168.9 ± 8.1 | 162.3 ± 10.2 | 0.09 |
| Weight (kg) | 65.1 ± 13.2 | 59.2 ± 10.2 | 0.19 |
| Cough Score | 6.7 ± 4.4 | 7.3 ± 8.9 | 0.84 |
| PEF (mL) | 479.3 ± 112.8 | 381.8 ± 137.0 | 0.07 |
| FEV1 (L) | 3.5 ± 0.6 | 3.0 ± 0.9 | 0.13 |
| FEV1/FVC (%) | 85.3 ± 8.7 | 84.8 ± 5.3 | 0.86 |
| SABA usage (/day) | 0.6 ± 0.9 | 0.6 ± 1.0 | 0.95 |
Data are expressed as the mean ± SD. For comparison of patient characteristics, the unpaired t-test and chi-squared test were used.
Key: ICS, inhaled corticosteroid; SABA, short-acting beta-agonist; LTRA, leukotriene receptor antagonist; PEF, peak expiratory flow; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity.